-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Oncology Q3 EPS $(0.08), Inline, Sales $1.494M Miss $2.500M Estimate

Benzinga·08/14/2026 20:58:09
Listen to the news
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $1.494 million which missed the analyst consensus estimate of $2.500 million by 40.24 percent.